DE60032784T2 - Markerproteine für prostatakrebs - Google Patents

Markerproteine für prostatakrebs Download PDF

Info

Publication number
DE60032784T2
DE60032784T2 DE60032784T DE60032784T DE60032784T2 DE 60032784 T2 DE60032784 T2 DE 60032784T2 DE 60032784 T DE60032784 T DE 60032784T DE 60032784 T DE60032784 T DE 60032784T DE 60032784 T2 DE60032784 T2 DE 60032784T2
Authority
DE
Germany
Prior art keywords
sample
prostate cancer
marker
markers
patient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Revoked
Application number
DE60032784T
Other languages
German (de)
English (en)
Other versions
DE60032784D1 (de
Inventor
Tai-Tung Cupertino YIP
Christine Cupertino YIP
L. George Virginia Beach WRIGHT
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eastern Virginia Medical School
Aspira Womens Health Inc
Original Assignee
Eastern Virginia Medical School
Ciphergen Biosystems Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22568045&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60032784(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Eastern Virginia Medical School, Ciphergen Biosystems Inc filed Critical Eastern Virginia Medical School
Publication of DE60032784D1 publication Critical patent/DE60032784D1/de
Application granted granted Critical
Publication of DE60032784T2 publication Critical patent/DE60032784T2/de
Anticipated expiration legal-status Critical
Revoked legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57434—Specifically defined cancers of prostate

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE60032784T 1999-10-07 2000-10-06 Markerproteine für prostatakrebs Revoked DE60032784T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15842299P 1999-10-07 1999-10-07
US158422P 1999-10-07
PCT/US2000/027682 WO2001025791A2 (en) 1999-10-07 2000-10-06 Prostate cancer marker proteins

Publications (2)

Publication Number Publication Date
DE60032784D1 DE60032784D1 (de) 2007-02-15
DE60032784T2 true DE60032784T2 (de) 2007-11-08

Family

ID=22568045

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60032784T Revoked DE60032784T2 (de) 1999-10-07 2000-10-06 Markerproteine für prostatakrebs

Country Status (7)

Country Link
EP (1) EP1224466B1 (US20040097461A1-20040520-C00002.png)
JP (1) JP2004500553A (US20040097461A1-20040520-C00002.png)
AT (1) ATE350662T1 (US20040097461A1-20040520-C00002.png)
AU (1) AU7868300A (US20040097461A1-20040520-C00002.png)
CA (1) CA2386669A1 (US20040097461A1-20040520-C00002.png)
DE (1) DE60032784T2 (US20040097461A1-20040520-C00002.png)
WO (1) WO2001025791A2 (US20040097461A1-20040520-C00002.png)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001249275B2 (en) * 2000-03-20 2005-12-08 Eastern Virginia Medical School Prostate cancer markers
AUPQ886100A0 (en) * 2000-07-19 2000-08-10 Biotron Limited Diagnostic test
GB2379737A (en) * 2001-09-05 2003-03-19 Univ Geneve Diagnostic method for spongiform encephalopathy disease
AU2003211157A1 (en) * 2002-02-21 2003-09-09 Eastern Virginia Medical School Protein biomarkers that distinguish prostate cancer from non-malignant cells
EP1556702A2 (en) 2002-10-30 2005-07-27 Proteome Sciences Plc Diagnostic methods for transmissible spongiform encephalopathies (prion diseases)
ATE502300T1 (de) 2002-12-26 2011-04-15 Nitto Boseki Co Ltd Immunoassay-verfahren
WO2004090550A2 (en) 2003-04-08 2004-10-21 Colotech A/S A method for detection of colorectal cancer in human samples
US7425700B2 (en) 2003-05-22 2008-09-16 Stults John T Systems and methods for discovery and analysis of markers
JP4568551B2 (ja) * 2004-07-28 2010-10-27 一晃 掛樋 糖たん白質糖鎖の分析方法及び非標識糖鎖の製造方法
BRPI0607016A2 (pt) * 2005-04-07 2009-08-04 Mosaiques Diagnostics & Therap marcadores polipeptìdicos para o diagnóstico de cáncer de próstata
CN101454331A (zh) 2006-03-24 2009-06-10 菲诺梅诺米发现公司 有效用于诊断前列腺癌的生物标记，及其方法
GB0617429D0 (en) 2006-09-05 2006-10-18 Electrophoretics Ltd Markers of renal transplant rejection and renal damage
EP2012127A3 (en) * 2007-07-03 2009-03-11 Koninklijke Philips Electronics N.V. Diagnostic markers for detecting prostate cancer
CA2798812A1 (en) * 2010-05-21 2011-11-24 Ohmx Corporation Detection of cancer by assaying psa enzymatic activity
US20140134658A1 (en) * 2010-05-21 2014-05-15 Notrhwestern University, An Illinois Not For Profit Corporation Psa enzymatic activity: a new biomarker for assessing prostate cancer aggressiveness
CA2835806A1 (en) 2011-05-13 2012-11-22 King's College London Methods and compositions relating to platelet sensitivity
WO2015042493A2 (en) * 2013-09-20 2015-03-26 Ohmx Corporation Psa enzymatic activity: a new biomarker for assessing prostate cancer aggressiveness
CA3146525A1 (en) 2019-08-05 2021-02-11 William Manning Systems and methods for sample preparation, data generation, and protein corona analysis

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6143864A (en) * 1994-06-28 2000-11-07 Merck & Co., Inc. Peptides
US5866679A (en) * 1994-06-28 1999-02-02 Merck & Co., Inc. Peptides
US5807978A (en) * 1995-06-07 1998-09-15 Kokolus; William J. Immunogenic peptides of prostate specific antigen
EP0975963A1 (en) * 1997-03-11 2000-02-02 Sloan-Kettering Institute For Cancer Research Prostate specific antigen substrates
US6207370B1 (en) * 1997-09-02 2001-03-27 Sequenom, Inc. Diagnostics based on mass spectrometric detection of translated target polypeptides
US6300088B1 (en) * 1997-11-24 2001-10-09 Duke University Method of detecting prostate specific antigen
WO1999037811A1 (en) * 1998-01-21 1999-07-29 Urocor, Inc. Biomarkers and targets for diagnosis, prognosis and management of prostate disease
EP1080194A2 (en) * 1998-05-29 2001-03-07 Incyte Pharmaceuticals, Inc. Human transmembrane proteins

Also Published As

Publication number Publication date
DE60032784D1 (de) 2007-02-15
CA2386669A1 (en) 2001-04-12
ATE350662T1 (de) 2007-01-15
EP1224466A2 (en) 2002-07-24
AU7868300A (en) 2001-05-10
EP1224466B1 (en) 2007-01-03
WO2001025791A2 (en) 2001-04-12
JP2004500553A (ja) 2004-01-08
WO2001025791A3 (en) 2001-12-27

Similar Documents

Publication Publication Date Title
DE60032784T2 (de) Markerproteine für prostatakrebs
EP1269194B1 (en) Prostate cancer markers
US7297556B2 (en) Method of diagnosing nephrotic syndrome
CN101310185A (zh) 前列腺癌的生物标记
KR20050062518A (ko) 난소암의 검출을 위한 생물 마커의 용도
EP1496928A1 (en) Serum biomarkers in hepatocellular carcinoma
DE112018007705T5 (de) Magnetisches Perlen-Nukleinsäure Aptamer-Multitargetmolekül-Simultan-Nachweisverfahren und Kit
AU2001249275A1 (en) Prostate cancer markers
DE602004013350T2 (de) Elastinpeptid-fingerabdrücke und analyseverfahren für mit copd in verbindung stehendes mmp12
EP1650305B1 (de) Mutanten der den Faktor VII aktivierenden Protease und Nachweisverfahren mit spezifischen Antikörpern
US20070087392A1 (en) Method for diagnosing head and neck squamous cell carcinoma
US20030228639A1 (en) Prostate cancer markers
WO2003072710A2 (en) Protein biomarkers that distinguish prostate cancer from non-malignant cells
EP0955377B1 (de) Verfahren zum Nachweis einer bei Apoptose aktivierten Protease
EP1133697B1 (de) Verfahren zur modifikation und identifikation funktioneller stellen in proteinen
WO2002023200A2 (en) Human breast cancer biomarkers
EP1541676B1 (de) Gegen das Prothrombin-Fragment F1+2 gerichtete Antikörper, ihre Herstellung und Verwendung
JP2005510721A (ja) アルツハイマー病を予測するｉｇラムダバイオポリマーマーカー
JP2005510731A (ja) Ｉｉ型糖尿病のスクリーニングのためのフィブリノゲンバイオポリマーマーカーおよびその使用
CA2525740A1 (en) Biomarkers for the differential diagnosis of pancreatitis and pancreatic cancer
JP2005523420A (ja) アルツハイマー病を示す補体ｃ３前駆体バイオポリマーマーカー
CA2485970A1 (en) Methods for diagnosing htlv-i-mediated diseases
JP2005523419A (ja) インスリン耐性を示すフィブロネクチンおよびフィブリノゲンバイオポリマーマーカー
EP0947832A1 (de) Immunologisches Verfahren zur Bestimmung von PSA
CA2473814A1 (en) Method and markers for the diagnosis of renal diseases

Legal Events

Date Code Title Description
8363 Opposition against the patent
8339 Ceased/non-payment of the annual fee
8331 Complete revocation